Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Apr;103(4):296-301.
doi: 10.1007/s00347-006-1324-9.

[Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment]

[Article in German]
Affiliations
Review

[Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment]

[Article in German]
T Ness et al. Ophthalmologe. 2006 Apr.

Abstract

Giant cell arteritis (arteritis temporalis) is the most common form of systemic vasculitis in the elderly. A series of symptoms such as new-onset headache, jaw claudication, proximal myalgia, weight loss, and fever may lead to the diagnosis. However, there is also a silent or occult presentation with minor or no systemic symptoms, especially no headache. A number of laboratory values (erythrocyte sedimentation rate, CRP, fibrinogen, thrombocytes, and cardiolipin antibodies) indicate giant cell arteritis, but none of this proves the diagnosis. Temporal artery biopsy is the gold standard for diagnosis of giant cell arteritis. Due to skip lesions, a negative result does not exclude the diagnosis. The most important complication of giant cell arteritis is visual loss in one or both eyes due to AION or retinal artery occlusion. Usually, visual loss is irreversible even with therapy. Corticosteroids are the drug of choice to treat giant cell arteritis. Therapy is required for a long time, monitored by parameters of inflammation (ESR, CRP).

PubMed Disclaimer

References

    1. Br J Rheumatol. 1992 Feb;31(2):103-5 - PubMed
    1. Acta Med Scand. 1986;220(5):465-9 - PubMed
    1. Lancet. 2000 May 6;355(9215):1572-3 - PubMed
    1. N Engl J Med. 1998 Jul 30;339(5):292-9 - PubMed
    1. J Clin Pathol. 2000 Feb;53(2):137-9 - PubMed

MeSH terms

Substances

LinkOut - more resources